Literature DB >> 2503359

[Evoked potentials with intrathecal and systemic corticosteroid therapy in multiple sclerosis].

R Heun1, W Emser, K Schimrigk.   

Abstract

46 MS-patients were treated by systemic or intrathecal administration of steroids. Before and three weeks after the beginning of the treatment, we measured the latencies of visual and somatosensory evoked potentials and examined clinically according to the Expanded Disability Status Scale (EDSS). Only one patient showed significant changes in VEP latencies, SEP showed equivalent results before and after therapy. In contrast, in 24 out of 46 patients the clinical examination revealed a change in EDSS. As a consequence visual and somatosensory evoked potentials can not be regarded as adequate tools for short-term assessment in therapeutic trials.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2503359

Source DB:  PubMed          Journal:  EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb        ISSN: 0012-7590


  2 in total

1.  Intrathecal versus systemic corticosteroids in the treatment of multiple sclerosis: results of a pilot study.

Authors:  R Heun; U Sliwka; H Rüttinger; K Schimrigk
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

2.  Efficacy of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients with spinal symptoms.

Authors:  Kerstin Hellwig; Franz Josef Stein; Horst Przuntek; Thomas Müller
Journal:  BMC Neurol       Date:  2004-11-07       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.